Brains for the Cure - Brain Tumor News
Get Help With Brain Tumors
New Drug Crosses Blood-brain Barrier and kills glioblastoma cells A team led by Dr. Priya Kumthekar of Northwestern University, a long-time Head for the Cure
Although brain tumors and brain cancer continues to impact thousands of people each year, this disease can still feel incredibly isolating. As more awareness is
The Ivy Brain Tumor Center at Barrow Neurological Institute announced the treatment of their first patient in a Phase 0 clinical trial for newly diagnosed glioblastoma and
OncoSynergy, Inc. launched the company’s First-in-Human Phase 1 clinical trial evaluating a treatment of recurrent glioblastoma. Today they announced the first patient has been treated
Dr. John Boockvar, a Head for the Cure partner on our New York–area events and one of the subjects of the medical docu-drama Lenox Hill
In a global clinical trial, GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment), Henry Ford Cancer Institute is the first to activate two new treatments
Brains for the Cure’s writers review several important developments in recent pediatric brain tumor research.
When treating a patient, no matter their diagnosis, a doctor learns about the patient, but also their family and friends. Dr. Nick Avgeropoulos, from Orlando